Hangzhou Biotest Biotech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hangzhou Biotest Biotech Co., Ltd.

Why is Hangzhou Biotest Biotech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -38.86% and Operating profit at -63.30% over the last 5 years

With a fall in Net Sales of -13.84%, the company declared Very Negative results in Sep 25

DEBT-EQUITY RATIO (HY) Highest at -65.15 %
NET PROFIT(Q) At CNY 9.86 MM has Fallen at -42.12%
DEBTORS TURNOVER RATIO(HY) Lowest at 5.54 times

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hangzhou Biotest Biotech Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Hangzhou Biotest Biotech Co., Ltd.

-3.22%

1.16

65.49%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-29.58%

EBIT Growth (5y)

-70.53%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.67

Sales to Capital Employed (avg)

0.20

Tax Ratio

15.45%

Dividend Payout Ratio

207.96%

Pledged Shares

Institutional Holding

ROCE (avg)

119.24%

ROE (avg)

13.43%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

188

Industry P/E

Price to Book Value

2.24

EV to EBIT

547.89

EV to EBITDA

160.82

EV to Capital Employed

4.07

EV to Sales

8.67

PEG Ratio

Dividend Yield

ROCE (Latest)

0.74%

ROE (Latest)

1.20%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 3.39 times

RAW MATERIAL COST(Y)

Fallen by -19.35% (YoY

-30What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 66.48 MM

NET SALES(HY)

At CNY 229.32 MM has Grown at -9.45%

ROCE(HY)

Lowest at 1.27%

DEBT-EQUITY RATIO (HY)

Highest at -59.44 %

OPERATING PROFIT(Q)

Lowest at CNY -5.14 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -5.75 %

PRE-TAX PROFIT(Q)

Lowest at CNY -12.21 MM

NET PROFIT(Q)

Lowest at CNY -10.33 MM

EPS(Q)

Lowest at CNY -0.07

Here's what is working for Hangzhou Biotest Biotech Co., Ltd.

Inventory Turnover Ratio

Highest at 3.39 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -19.35% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hangzhou Biotest Biotech Co., Ltd.

Pre-Tax Profit

At CNY -12.21 MM has Fallen at -217.16%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -10.33 MM has Fallen at -215.5%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 66.48 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 229.32 MM has Grown at -9.45%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Debt-Equity Ratio

Highest at -59.44 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit

Lowest at CNY -5.14 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -5.75 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY -12.21 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY -10.33 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -0.07

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)